Blueberries Medical Corp
CNSX:BBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Blueberries Medical Corp
Cash from Financing Activities
Blueberries Medical Corp
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Blueberries Medical Corp
CNSX:BBM
|
Cash from Financing Activities
CA$1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Financing Activities
-$742m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Financing Activities
CA$269.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
21%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Financing Activities
-$19.9m
|
CAGR 3-Years
-90%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash from Financing Activities
$25.2m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Financing Activities
CA$5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
Blueberries Medical Corp
Glance View
Blueberries Medical Corp. engages in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-04-09. The firm is engaged in the cultivation and development of medicinal cannabis and related products. The firm is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.
See Also
What is Blueberries Medical Corp's Cash from Financing Activities?
Cash from Financing Activities
1.1m
CAD
Based on the financial report for Sep 30, 2025, Blueberries Medical Corp's Cash from Financing Activities amounts to 1.1m CAD.
What is Blueberries Medical Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-1%
Over the last year, the Cash from Financing Activities growth was 81%.
